How Mayo Clinic Advances Autoimmune Neurology Testing
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care. Expanding access to advanced testing (00:32): Discover how a new collaboration with Pathology Asia Holdings will expand access to molecular and genomic testing. Advancing DNA mutation detection (04:50): Hear about research to detect DNA mutations across the genome and its potential implications for clinical diagnostics. Innovating in autoimmune neurology (07:39): Learn how the unique dynamics of the Mayo Clinic Neuroimmunology Laboratory help drive innovation. Resources Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions Autoimmune neurology: At the forefront of a testing evolution Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicine Somatic mutations: Study advances DNA detection
